Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MNKD
MNKD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MNKD News
FDA Approves Afrezza for Pediatric Diabetes Management
2d ago
Newsfilter
U.S. Stocks Hit Record Highs, Dell Shares Surge 33%
1d ago
stocktwits
FDA Approves Afrezza for Pediatric Use, First Inhaled Insulin
1d ago
stocktwits
MannKind Receives FDA Approval for Afrezza in Children
1d ago
Newsfilter
MannKind's Inhaled Insulin Approved for Children
1d ago
seekingalpha
MannKind Set to Present Afrezza Data Amid FDA Decision
3d ago
stocktwits
MannKind Unveils New Afrezza Data Ahead of FDA Review
4d ago
Newsfilter
United Therapeutics' Tyvaso Shows Positive Results for Lung Fibrosis
May 19 2026
stocktwits
VentriPoint Diagnostics Showcases AI Cardiac Imaging Platform at Major Conference
May 12 2026
PRnewswire
VentriPoint Diagnostics Showcases AI Cardiac Imaging Platform at Major Conference
May 12 2026
Newsfilter
MannKind Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
MannKind Q1 2026 Earnings Report Analysis
May 06 2026
seekingalpha
MannKind Partners with United Therapeutics for New Drug Development
May 06 2026
stocktwits
MannKind and United Therapeutics Expand Collaboration Agreement
May 06 2026
seekingalpha
MannKind Partners with United Therapeutics to Advance Ralinepag DPI
May 06 2026
Newsfilter
MannKind Corporation Showcases Growth Potential at Healthcare Conference
Mar 27 2026
Yahoo Finance
Show More News
